Skip to main content
Premium Trial:

Request an Annual Quote

TeselaGen, Redbiotech to Co-create Herpesvirus Vaccine Library

Premium

This week, TeselaGen Biotechnology and Redbiotec announced their plans to build a library that will be used to develop vaccines for the Herpesvirus.

According to the partners, Redbiotec will contribute its proprietary rePAX technology, which is used to produce virus-like particles and multi-protein complexes and its expertise in the field of human cytomegalovirus, while TeselaGen will provide infrastructure for building and modifying DNA and automatic library creation as well as statistical learning approaches to model the performance of VLPs and multi-protein complexes and to feed such information back into the design process.

The companies' goal is to build a verified library for Herpesvirus vaccine development and testing that will help reveal potential causes of virus latency and elucidate virus-triggered cancer mechanisms. It will also enable the optimization and improvement of new and existing vaccine candidates, they said.

This is the second partnership TeselaGen has announced this year. In July, it signed a multi-year licensing agreement that allows Genomatica to use its automated DNA cloning software for microbial strain engineering projects (BI 7/12/2013).

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.